Investor results briefing

RNS Number : 0968U

Omega Diagnostics Group PLC

21 November 2019

 

Omega Diagnostics Group PLC

("Omega" or "the Company" or the "Group")

Investor results briefing

Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces it will be hosting an investor evening for all investors on Wednesday 4 December 2019, accompanying the interim results for six months ended 30 September 2019.

The event will take place in the No.1 Cornhill, London, EC3V 3ND at 4.30pm for a 4.45pm start. This will be followed by light refreshments, and a chance to network.

The results presentation will be available on the Company website shortly after the event. No new information will be disclosed. 

If you would like to register to attend the briefing, or require further information, please contact Walbrook PR on 020 7933 8780 or email [e-mail].

Contacts:

Omega Diagnostics Group PLC	Tel: [phone]
Bill Rhodes, Interim Non-Executive Chairman	www.omegadiagnostics.com
Colin King, Chief Executive
Kieron Harbinson, Group Finance Director
finnCap Ltd	Tel: [phone]
Geoff Nash/James Thompson/Hannah Boros (Corporate Finance)
Camille Gochez (ECM)
Walbrook PR Limited	Tel: [phone] or [e-mail]
Paul McManus	Mob: [phone]
Lianne Cawthorne	Mob: [phone]

 

END

 

 

NRABXBDBGSDBGCG